London -- (MARKET WIRE) -- October 31, 2006 --
For Immediate Release 31st October 2006
SkyePharma PLC
SKYEPHARMA TO PRESENT AT COWEN AND COMPANY
7TH ANNUAL GLOBAL HEALTH CARE CONFERENCE
LONDON, UK, 31 October 2006 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announces
today that the Company's Chief Executive Officer, Frank Condella, will make a
presentation at the Cowen and Company 7th Annual Global Health Care Conference
at the Landmark London Hotel in London, UK. Mr. Condella will deliver his
presentation on Tuesday, November 7, 2006 at 5.30 p.m. (GMT). Investors may
access a live webcast of the presentation at
www.skyepharma.com under the
Investor Relations tab. The presentation will be archived for 3 months.
For further information please contact:
SkyePharma PLC +44 207 491 1777
Frank Condella, Chief Executive Officer
Ken Cunningham, Chief Operating Officer
Buchanan Communications +44 207 466 5000
Tim Anderson / Mark Court / Rebecca Skye Dietrich
The Trout Group + 1 617 583 1308
Seth Lewis
About SkyePharma PLC
SkyePharma PLC develops pharmaceutical products benefiting from world-leading
drug delivery technologies that provide easier-to-use and more effective drug
formulations. There are now eleven approved products incorporating SkyePharma's
technologies in the areas of oral, injectable, inhaled and topical delivery,
supported by advanced solubilisation capabilities. For more information, visit
www.skyepharma.com.
This information is provided by RNS
The company news service from the London Stock Exchange